Hormone Replacement Therapy Drugs List: Categories, Forms, Risks, and Cost Drivers

Start with the categories behind the list

A hormone medication list is useful when you treat it as a map of different decisions rather than a ranking of products. Menopausal hormone therapy uses estrogen, progestin, or both; sometimes testosterone is also added. Hormone therapy can help relieve menopause symptoms by replacing some hormones the body no longer makes.

The main categories to separate are:

• Systemic estrogen: Medication that enters the bloodstream and is generally used for symptoms affecting the body more broadly, such as hot flashes.
• Progestin or progesterone: A hormone often paired with estrogen when you still have a uterus.
• Low-dose vaginal therapy: Local treatment for vaginal or urinary symptoms, with much less bloodstream exposure than systemic treatment.
• Testosterone replacement: A separate pathway that requires appropriate symptoms, testing, indication, and monitoring.

Your symptoms, whether you have a uterus, the route of administration, medical history, goals, and follow-up plan all change which category deserves discussion. Use the sections below to identify questions for a qualified clinician, not to select a medication independently.

Systemic estrogen for broader menopause symptoms

Systemic estrogen comes in pills, patches, gels, sprays, or a vaginal ring and enters the bloodstream. Estrogen can reduce hot flashes and some vaginal and urinary symptoms, and it can help prevent bone thinning in menopausal women. The Menopause Society’s position statement says hormone therapy remains the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture.

The route matters. A pill, patch, gel, spray, and ring may all belong to an estrogen discussion, but they do not create the same practical questions about application, absorption, cost, or clot risk. A vaginal ring also needs careful identification because some ring formulations provide systemic estrogen, while low-dose vaginal products are used locally for genitourinary symptoms and generally result in much less bloodstream exposure. Ask which formulation and dose are being considered and what symptom it is intended to address.

A separate published program example illustrates why a medication price does not always equal a complete care price: most members without insurance in the cited FOLX program pay about $69–$98 per month for estrogen gender-affirming hormone therapy that includes membership, clinician visits, labs, and medications. That figure describes that program and population, not menopause care in Fredericksburg or a local quote.

Progestin and the uterus

Progestin changes the estrogen conversation when you still have a uterus. If you still have a uterus, progestin is used with estrogen in combined hormone therapy. If you do not have a uterus, estrogen may be given without progestin.

Your clinician may discuss one of two broad schedules:

• Continuous-combined therapy: You take estrogen and progestin every day.
• Cyclic therapy: You take estrogen daily and add progestin for 10 to 14 days each month, usually as a pill.

The choice is not a preference you can safely make from a list alone. It depends on your anatomy, symptoms, bleeding pattern, medical history, treatment goals, and the specific product. Ask how the regimen protects the uterus when that protection is relevant, what bleeding changes may occur, and which follow-up findings would require a change in the plan.

Local vaginal options are a separate route question

Low-dose vaginal estrogen is used for vaginal symptoms; very little enters the bloodstream, so the risks are far lower than with systemic therapy. Vaginal estrogen works locally on vaginal tissue and the surrounding area to treat genitourinary syndrome of menopause, with minimal bloodstream absorption.

Common local forms described in medication resources include vaginal estradiol, vaginal estriol, and vaginal suppositories. Vaginal estradiol is available as a cream or insert and delivers estradiol directly to vaginal tissue. This route question matters because a local product intended for vaginal symptoms is not interchangeable with systemic estrogen intended for broader symptoms.

Keep other formulations separate as well. Estradiol gel is a transdermal product that delivers a daily wave of standard estradiol and absorbs through the skin continuously over 24 hours; it is not the same as a low-dose vaginal product. Bi-est cream is a custom-compounded blend of estradiol and estriol, typically mixed in an 80:20 or 50:50 ratio.

Before using any product, ask what tissue or symptom it targets, how much enters the bloodstream, whether it is commercially manufactured or compounded, and what monitoring applies.

Testosterone replacement follows a different pathway

Testosterone replacement is not simply another name for menopause hormone therapy. Doctor-prescribed testosterone replacement can be safe and effective for men diagnosed with consistently abnormal low testosterone production and related symptoms. A patient resource describes normal testosterone levels as 300–1,000 ng/dL depending on age and the laboratory used, and says testosterone must be measured more than once for accurate assessment.

Testosterone therapy is recommended only for hypogonadism patients and is not FDA-approved to improve strength, athletic performance, physical appearance, or problems associated with aging. That distinction matters if your goal is related to energy, body composition, exercise, or aging rather than a documented hormone deficiency with related symptoms.

Available treatment methods include:

• Injections
• Gels or solutions
• Skin patches
• Buccal tablets applied to the gums
• Pellets implanted under the skin
• Nasal gel

The method depends on the cause of low testosterone, your preferences, cost, tolerance, and fertility concerns. Testosterone injections may be self- or doctor-administered in a muscle every 1–2 weeks, or given at a clinic every 10 weeks when longer-acting. Injections may also cause discomfort and fluctuating symptoms. Pellets are implanted under the skin surgically every 3–6 months and may cause the pellet to come out through the skin, site infection or bleeding, or returning hypogonadism symptoms toward the end of the dose period.

Testosterone therapy carries risks including elevated red blood cell count, acne, sleep apnea, and possible prostate or breast enlargement, and it must be monitored regularly. It should not be given to people with blood clots, prostate or breast cancer or suspected cancer, elevated PSA levels, an enlarged prostate causing difficulty urinating, or a heart attack or stroke within the last six months. Testosterone therapy should be done correctly, monitored regularly, and use only FDA-approved hormones.

Compare options by route, risk, and formulation

A personalized approach to hormone therapy includes regular reassessment of risks and benefits. Age, time since menopause, formulation, personal health history, symptoms, goals, and testing all affect the discussion.

Use these comparison questions:

• Route: Transdermal estrogen may have thrombosis-sparing properties compared with oral estrogen. Combined and estrogen-only hormone therapy are associated with a small increased risk of stroke and deep vein thrombosis; nonoral forms may have less deep-vein-thrombosis risk than oral forms.
• Uterine protection: If you still have a uterus, estrogen alone is not the same choice as estrogen paired with progestin.
• Medical history: Hormone therapy is not a good choice for everyone. If you have breast or uterine cancer, unexplained uterine bleeding, liver disease, a history of blood clots, or cardiovascular disease, discuss whether it is appropriate with a healthcare professional before pursuing it.
• Breast and gallbladder considerations: Combined hormone therapy has a small increased risk of breast cancer. Estrogen therapy with or without progestin has a small increased risk of gallbladder disease, with the greatest gallbladder risk from oral forms.
• Timing: For women younger than 60 years or within 10 years of menopause onset, the benefit-risk ratio of hormone therapy is favorable. That does not settle suitability for you; the full history and treatment context still matter.
• Compounding: Compounded bioidentical hormone therapy presents safety concerns, including minimal government regulation and monitoring, overdosing or underdosing, impurities or lack of sterility, limited scientific efficacy and safety data, and no label outlining risks.

A published overview also says most HRT risks are small when treatment starts in the first 10 years of menopause or before the age of 60, while noting that risks vary by formulation and personal history. Treat that as context for a conversation, not as a personal eligibility rule.

Prepare the clinician conversation

Start with the information that can change the medication category, route, or monitoring plan. Before taking estrogen and progestin, tell your doctor or pharmacist about allergies, medicines and supplements, unusual vaginal bleeding, cancer, liver disease, pregnancy plans, and tobacco use.

Bring or write down:

• Your main symptoms, when they began, and how they affect sleep, work, exercise, sexual health, or daily routines.
• Whether you have a uterus and any history of hysterectomy, unusual bleeding, cancer, blood clots, stroke, heart disease, liver disease, or migraine.
• Every prescription, over-the-counter medicine, vitamin, supplement, and herbal product you use.
• Your goals, concerns about route or cost, fertility concerns where relevant, and questions about alternatives.
• Any prior hormone treatment, including the product, route, dose, response, and adverse effects.

Do not start St. John’s wort or other new medicines, supplements, or herbal products while using estrogen and progestin without discussing them with a healthcare provider. Use estrogen and progestin patches exactly as prescribed; these patches are usually applied once or twice weekly, depending on the product. If you use a patch and will have surgery or bedrest, talk to your doctor about stopping it at least 4 to 6 weeks beforehand.

True You Health and Wellness describes a personalized perimenopause process that considers your particular issues and health history. Our hormone replacement therapy process includes comprehensive labs, a thorough conversation, and therapy only when the data and symptoms support it. The duration of hormone therapy depends on your goals, symptoms, and health over time, and we review it regularly with you. If hormone therapy is not appropriate, we discuss alternatives to address symptoms.

Estimate the full cost instead of one drug price

HRT monthly costs vary by formulation, generic or brand status, insurance coverage, pharmacy, dosage, and discount-card use. Total hormone-treatment costs may also include the prescription, consultation fees, laboratory testing, and follow-up care, which may differ by provider. Ask for the full pathway cost rather than comparing pharmacy prices alone.

Published price examples show how wide the spread can be:

• One cost overview says generic options can start under $10 per month, while brand-name formulations can cost over $500 per month. The same overview reports generic oral estradiol and progesterone often starting at less than $10 per month, while brand-name patches, gels, or rings can cost several hundred dollars per month at retail prices.
• A June 4, 2018 cost report describes prices ranging from $10 per month for a 90-day supply of generic estrogen tablets to more than $500 for a 90-day vaginal ring. Because that report is from 2018, use it as an illustration of price variation rather than a current local quote.
• Reported transdermal estrogen costs are $26–$168 per month for generic products and $58–$80 per month for the cited Hone cost.
• Progesterone is available in pills and cream; reported generic costs are $9–$79 per month, and the cited Hone cost is $49–$79 per month.
• Reported vaginal estrogen costs are $40–$212 per month for generic products and $40–$65 per month for the cited Hone cost.
• Reported vaginal DHEA costs are $46–$90 per month for compounded products and $38 per month for the cited Hone cost.
• Another report lists an average monthly cost of $70 with insurance and $90 for self-pay compounded hormone replacement therapy.
• The same report lists average monthly costs with insurance of $172 for an estradiol vaginal ring, $142 for estradiol gel, $55 for estradiol patches, and $7 for estradiol tablets.

These figures describe different products, sources, coverage conditions, and populations. They are not a price quote for True You Health and Wellness. Compounded bioidentical preparations are generally not covered by commercial insurance, while some FDA-approved commercial bioidentical products may be covered depending on the plan. FDA-approved bioidentical products are commercially manufactured and standardized through the FDA drug-approval process; compounded bioidentical preparations are made by a licensed pharmacist for an individual patient under a specific prescription.

Before you commit, ask which costs cover the medication, which cover testing or follow-up, whether the quoted amount assumes insurance or self-pay, and whether the product is FDA-approved or compounded.

Know when a possible reaction needs prompt help

Possible medication reactions should not be handled by changing the dose on your own. Call your doctor immediately if you have abnormal or unusual vaginal bleeding while using estradiol.

Call your doctor immediately for any of these symptoms while using estradiol:

• Sudden, severe headache
• Speech problems or sudden vision loss
• Chest pain or chest heaviness
• Coughing up blood
• Sudden shortness of breath
• Pain, tenderness, or redness in one leg

Do not wait for a routine medication review when one of these symptoms appears. Have the medication name, route, dose, start date, and other medicines available when you contact a qualified professional. If you are considering treatment but have concerning symptoms before starting, pause the medication decision and seek qualified guidance rather than using the list to self-triage.

Choose a documented local evaluation path

If you are in Fredericksburg or nearby and want to discuss hormone therapy, look for an evaluation that connects symptoms, history, testing, medication choice, and follow-up instead of treating one lab value as the whole decision.

True You Health and Wellness describes its local process this way: we evaluate whether hormone therapy may help with perimenopause when laboratory results and symptoms support it, and we use careful evaluation to assess which hormones have shifted in women and whether treatment is necessary. Our care is cash-based, allowing for transparent costs and comprehensive testing. We also provide discreet care with in-person testing and virtual follow-up.

Monitoring belongs in the initial conversation. One published source states that hormone levels should be monitored at least twice per year while taking hormone replacement therapy to support ongoing safety. That interval is not a universal instruction for every medication or situation, so ask what will be monitored, when it will be checked, and what result would change the plan.

Bring your category questions, medical history, current medication list, route preferences, cost questions, and warning-sign concerns to the evaluation. True You Health and Wellness does not present a particular drug as appropriate for every person; the stated process is therapy only when the data and symptoms support it.

Start the next conversation with your questions ready

The useful next step is a focused conversation about which hormone category fits your symptoms, whether the route changes the trade-offs, how your medical history affects suitability, what testing and monitoring will be used, and what the complete cost includes. Bring this list as a question guide, not as a prescription or a reason to start, stop, or change medication on your own.

A qualified clinician should determine your individual suitability, medication, dose, combination, and monitoring plan. If your concerns include unusual bleeding or the serious symptoms listed above, address those promptly rather than waiting for routine planning.

What should I ask before discussing hormone replacement therapy medications?

What should I look for in a hormone replacement therapy drugs list before discussing it with a clinician?

Use it to sort options by hormone, route, intended symptom, and monitoring needs—not to choose a medication. Confirm whether a product is systemic or local, whether you have a uterus, whether it is FDA-approved or compounded, and what testing, follow-up, and total costs apply. A qualified clinician or pharmacist should determine suitability, dose, combinations, and route.

Is every vaginal ring a local treatment?

No. Some vaginal-ring formulations provide systemic estrogen for broader symptoms, while low-dose vaginal products are intended for genitourinary symptoms and generally result in much less bloodstream exposure. Ask which formulation and dose are being considered, what symptom it targets, and how much hormone enters the bloodstream.

What costs should I confirm before starting hormone treatment?

Ask for separate estimates for the medication, consultation, laboratory testing, follow-up, and any monitoring. Also confirm whether the price assumes insurance or self-pay, whether the product is generic, brand-name, FDA-approved, or compounded, and whether pharmacy or dosage changes could alter the amount. Published prices vary widely and are not a local quote for True You Health and Wellness.